IcoSema, a combination therapy of basal insulin icodec and semaglutide, achieves a noninferior reduction in A1c levels compared with basal-bolus therapy in adults with T2D.

The addition of anagliptin to insulin and metformin therapy may improve glycemic control in patients with type 2 diabetes while maintaining an acceptable safety profile.

The Howard County Board of Education is suing Eli Lilly and Co., Novo Nordisk, CVS, United Health group and several other ...

The craziest way science has found to help reverse insulin resistance is drinking lemon juice. Scientific research is now ...

Added kilos, particularly around the abdomen, is a common fallout of Polycystic Ovary Syndrome in women, often causing insulin resistance and hormonal imbalance ...

Scientists have identified a simple blood test that measures insulin resistance which may also help doctors determine which ...

The diabetes conference featured a debate about over-the-counter glucose monitors and updates on upcoming devices, including ...

Pregnant women with type 1 diabetes who used hybrid closed-loop insulin delivery with Control-IQ technology spent more time ...

A study finds that inhaled insulin is as effective as traditional injections for children with type 1 diabetes during ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Researchers at a recent American Diabetes Association meeting reported that efsitora, experimental once-weekly insulin, was comparable to daily insulins in nearly a thousand adults with type 2 ...

Over time this may speed up hair thinning especially in those already prone to androgenetic alopecia male or female pattern ...